IL15 and neoplasm: The combination of IL-21 and IL-15 was also administered IP subsequent to human gp10025–33 (hgp10025–33) peptide vaccination of lymphopenic, tumor-bearing (B16F10 melanoma) C57BL/6 mice [3].